Lysophosphatidylcholine Acyltransferase 1 (LPCAT1) (Middle Region) Peptide
LPCAT1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all LPCAT1 products
- LPCAT1 (Lysophosphatidylcholine Acyltransferase 1 (LPCAT1))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-LPCAT1 antibody (Catalog #: ARP49884_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LPCAT1 (Lysophosphatidylcholine Acyltransferase 1 (LPCAT1))
- Synonyms
- AYTL2 Peptide, Aytl2 Peptide, RGD1311599 Peptide, PFAAP3 Peptide, lpcat Peptide, si:dkey-261i16.4 Peptide, zgc:158232 Peptide, 2900035H07Rik Peptide, BB137372 Peptide, BC005662 Peptide, C87117 Peptide, LPCAT Peptide, rd11 Peptide, lysophosphatidylcholine acyltransferase 1 Peptide, LPCAT1 Peptide, Lpcat1 Peptide, lpcat1 Peptide
- Background
-
Lysophosphatidylcholine (LPC) acyltransferase (LPCAT, EC 2.3.1.23) catalyzes the conversion of LPC to phosphatidylcholine (PC) in the remodeling pathway of PC biosynthesis.
Alias Symbols: AYTL2, FLJ12443, PFAAP3, lpcat
Protein Size: 534 - Molecular Weight
- 59 kDa
- Gene ID
- 79888
- NCBI Accession
- NM_024830, NP_079106
- UniProt
- Q8NF37
-
You are here:
